Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
One hundred years ago, Dr. Paul Ehrlich popularized the “magic bullet” concept for cancer therapy in which an ideal therapeutic agent would only kill the specific tumor cells it targeted. Since then, “targeted therapy” that specifically targets the molecular defects responsible for a patient's...
Main Authors: | Jiehua Zhou, John J. Rossi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116303092 |
Similar Items
-
Current progress of RNA aptamer-based therapeutics
by: Jiehua eZhou, et al.
Published: (2012-11-01) -
Aptamers as an approach to targeted cancer therapy
by: Fatemeh Mahmoudian, et al.
Published: (2024-03-01) -
Aptamers and antibodies: rivals or allies in cancer targeted therapy?
by: Lisa Agnello, et al.
Published: (2021-02-01) -
Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
by: Zhenjian Zhuo, et al.
Published: (2017-10-01) -
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
by: Zhaoying Fu, et al.
Published: (2020-04-01)